Status:
UNKNOWN
Depressive and Anxiety Disorders in Patients With Chronic Liver Diseases
Lead Sponsor:
Assiut University
Conditions:
Depression, Anxiety
Eligibility:
All Genders
18-90 years
Brief Summary
The aim of this observational study is to learn about the prevalence of depressive and anxiety disorders among patients with chronic liver diseases
Detailed Description
Major depressive disorder (MDD), or clinical depression, is a psychiatric disorder characterized by 2 or more weeks of persistently depressed mood accompanied by symptoms such as feelings of worthless...
Eligibility Criteria
Inclusion
- patients admitted or attending at Rajhi university hospital with chronic liver disease including: viral (hepatitis B and C), autoimmune (primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis), non-alcoholic steatohepatitis, Morbus Wilson and cryptogenic CLD.
- age group above 18 years old.
Exclusion
- patients with chronic liver disease with other psychiatric disorders other than depression and anxiety.
- patients with acute complication of chronic liver disease.
- patients with chronic liver disease who underwent liver transplation.
- patients with chronic liver disease under antiviral therapy.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT06113029
Start Date
December 1 2023
End Date
October 1 2024
Last Update
November 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Salma Ashraf Mohamed Badr
Asyut, Egypt, 71745